These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1255 related articles for article (PubMed ID: 23302119)

  • 141. [Prenatal diagnosis and outcome of pregnancy for women with high risks by screening of fetal free DNA from peripheral blood samples].
    Li Z; Duan H; Liu W; Zhu R; Li J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2024 Jan; 41(1):1-7. PubMed ID: 38171551
    [TBL] [Abstract][Full Text] [Related]  

  • 142. Clinical Validation of Non-Invasive Prenatal Testing for Fetal Common Aneuploidies in 1,055 Korean Pregnant Women: a Single Center Experience.
    Lee DE; Kim H; Park J; Yun T; Park DY; Kim M; Ryu HM
    J Korean Med Sci; 2019 Jun; 34(24):e172. PubMed ID: 31222985
    [TBL] [Abstract][Full Text] [Related]  

  • 143. Total alpha-fetoprotein and Lens culinaris agglutinin-reactive alpha-fetoprotein in fetal chromosomal abnormalities.
    Yamamoto R; Azuma M; Kishida T; Yamada H; Satomura S; Fujimoto S
    BJOG; 2001 Nov; 108(11):1154-8. PubMed ID: 11762654
    [TBL] [Abstract][Full Text] [Related]  

  • 144. Cell-free DNA analysis in maternal plasma in cases of fetal abnormalities detected on ultrasound examination.
    Benachi A; Letourneau A; Kleinfinger P; Senat MV; Gautier E; Favre R; Bidat L; Houfflin-Debarge V; Bouyer J; Costa JM;
    Obstet Gynecol; 2015 Jun; 125(6):1330-1337. PubMed ID: 26000504
    [TBL] [Abstract][Full Text] [Related]  

  • 145. Noninvasive prenatal screening for fetal common sex chromosome aneuploidies from maternal blood.
    Zhang B; Lu BY; Yu B; Zheng FX; Zhou Q; Chen YP; Zhang XQ
    J Int Med Res; 2017 Apr; 45(2):621-630. PubMed ID: 28357876
    [TBL] [Abstract][Full Text] [Related]  

  • 146. Population-based trends in invasive prenatal diagnosis for ultrasound-based indications: two decades of change from 1994 to 2016.
    Lostchuck E; Poulton A; Halliday J; Hui L
    Ultrasound Obstet Gynecol; 2019 Apr; 53(4):503-511. PubMed ID: 29877030
    [TBL] [Abstract][Full Text] [Related]  

  • 147. Rapid prenatal diagnosis of trisomy 21 in 5049 consecutive uncultured amniotic fluid samples by fluorescence in situ hybridisation (FISH).
    Witters I; Devriendt K; Legius E; Matthijs G; Van Schoubroeck D; Van Assche FA; Fryns JP
    Prenat Diagn; 2002 Jan; 22(1):29-33. PubMed ID: 11810646
    [TBL] [Abstract][Full Text] [Related]  

  • 148. First-trimester nuchal translucency measurement and echocardiography at 16 to 18 weeks of gestation in prenatal detection for trisomy 18.
    Cheng PJ; Liu CM; Chueh HY; Lin CM; Soong YK
    Prenat Diagn; 2003 Mar; 23(3):248-51. PubMed ID: 12627429
    [TBL] [Abstract][Full Text] [Related]  

  • 149. Karyotype analysis with amniotic fluid in 12365 pregnant women with indications for genetic amniocentesis and strategies of prenatal diagnosis.
    Xiao H; Yang YL; Zhang CY; Liao EJ; Zhao HR; Liao SX
    J Obstet Gynaecol; 2016; 36(3):293-6. PubMed ID: 26445265
    [TBL] [Abstract][Full Text] [Related]  

  • 150. European non-invasive trisomy evaluation (EU-NITE) study: a multicenter prospective cohort study for non-invasive fetal trisomy 21 testing.
    Verweij EJ; Jacobsson B; van Scheltema PA; de Boer MA; Hoffer MJ; Hollemon D; Westgren M; Song K; Oepkes D
    Prenat Diagn; 2013 Oct; 33(10):996-1001. PubMed ID: 23794121
    [TBL] [Abstract][Full Text] [Related]  

  • 151. Prospective first-trimester screening for trisomies by cell-free DNA testing of maternal blood in twin pregnancy.
    Sarno L; Revello R; Hanson E; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Jun; 47(6):705-11. PubMed ID: 26970114
    [TBL] [Abstract][Full Text] [Related]  

  • 152. Re-evaluation of risk for Down syndrome by means of the combined test in pregnant women of 35 years or more.
    Centini G; Rosignoli L; Scarinci R; Faldini E; Morra C; Centini G; Petraglia F
    Prenat Diagn; 2005 Feb; 25(2):133-6. PubMed ID: 15712330
    [TBL] [Abstract][Full Text] [Related]  

  • 153. Triple marker screening for fetal chromosomal abnormalities in Korean women of advanced maternal age.
    Kim SK; Bai SW; Chung JE; Jung YN; Park KH; Cho DJ; Kim JW; Yang YH; Song CH
    Yonsei Med J; 2001 Apr; 42(2):199-203. PubMed ID: 11371107
    [TBL] [Abstract][Full Text] [Related]  

  • 154. Effect of non-invasive prenatal testing as a contingent approach on the indications for invasive prenatal diagnosis and prenatal detection rate of Down's syndrome.
    Kou KO; Poon CF; Kwok SL; Chan KY; Tang MH; Kan AS; Leung KY
    Hong Kong Med J; 2016 Jun; 22(3):223-30. PubMed ID: 27149976
    [TBL] [Abstract][Full Text] [Related]  

  • 155. [Fetal diagnosis of Edwards syndrome].
    Tóth A; Hajdu K; Intödy Z; Rajczy K; László J
    Orv Hetil; 1990 Oct; 131(43):2355-6, 2359-60. PubMed ID: 2234934
    [TBL] [Abstract][Full Text] [Related]  

  • 156. Noninvasive Fetal Trisomy (NIFTY) test: an advanced noninvasive prenatal diagnosis methodology for fetal autosomal and sex chromosomal aneuploidies.
    Jiang F; Ren J; Chen F; Zhou Y; Xie J; Dan S; Su Y; Xie J; Yin B; Su W; Zhang H; Wang W; Chai X; Lin L; Guo H; Li Q; Li P; Yuan Y; Pan X; Li Y; Liu L; Chen H; Xuan Z; Chen S; Zhang C; Zhang H; Tian Z; Zhang Z; Jiang H; Zhao L; Zheng W; Li S; Li Y; Wang J; Wang J; Zhang X
    BMC Med Genomics; 2012 Dec; 5():57. PubMed ID: 23198897
    [TBL] [Abstract][Full Text] [Related]  

  • 157. Middle pregnancy ultrasound screening for fetal chromosomal diseases.
    Liu L; Zhou P; Cao Z; Tan X
    Mol Med Rep; 2017 Nov; 16(5):7641-7648. PubMed ID: 28944865
    [TBL] [Abstract][Full Text] [Related]  

  • 158. Open source non-invasive prenatal testing platform and its performance in a public health laboratory.
    Johansen P; Richter SR; Balslev-Harder M; Miltoft CB; Tabor A; Duno M; Kjaergaard S
    Prenat Diagn; 2016 Jun; 36(6):530-6. PubMed ID: 27027563
    [TBL] [Abstract][Full Text] [Related]  

  • 159. [Result of prenatal diagnosis for 151 high-risk women by noninvasive prenatal screening based on high-throughput sequencing].
    Jia Y; Zhang Y; Hao W; Shi D; Meng J; Zhao H; Lian Y; Xie L; Wang X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Oct; 34(5):759-763. PubMed ID: 28981949
    [TBL] [Abstract][Full Text] [Related]  

  • 160. [Preliminary analysis of the cause for the failure of non-invasive prenatal testing using cell-free fetal DNA derived from peripheral maternal blood].
    Zhang B; Shen C; Wang H; Cai Z; Lu B; Zhang X; Yu B; Wang T
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Jun; 35(3):329-333. PubMed ID: 29896725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 63.